From: MMP-8 C-799 T, Lys460Thr, and Lys87Glu variants are not related to risk of cancer
Author | Year | Origin | Cancer Type | Race | Source | Case | Control | Case | Control | P HWE | Method | Age range | NOS | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-799 T(rs11225395) | TT | TC | CC | TT | TC | CC | Case | Control | ||||||||||
Tsai | 2018 | Taiwan | Bladder cancer | Asian | PB | 375 | 375 | 37 | 152 | 186 | 38 | 140 | 197 | 0.082 | PCR-RFLP | mean 61.4 | mean 62.9 | 7 |
Hsiao | 2018 | Taiwan | Breast cancer | Asian | PB | 1232 | 1232 | 118 | 466 | 648 | 131 | 468 | 633 | 0.002 | PCR | NA | NA | 7 |
Pei | 2017 | Taiwan | Leukemia | Asian | PB | 266 | 266 | 29 | 98 | 139 | 32 | 105 | 129 | 0.145 | PCR-RFLP | mean 7.0 | mean 8.3 | 7 |
Shen | 2017 | Taiwan | Lung cancer | Asian | PB | 358 | 716 | 40 | 130 | 188 | 92 | 273 | 351 | 0.001 | PCR-RFLP | mean 64.0 | mean 64.8 | 7 |
Hung | 2017 | Taiwan | Oral cancer | Asian | PB | 788 | 956 | 90 | 284 | 414 | 126 | 364 | 466 | < 0.001 | PCR | mean 55.8 | mean 56.6 | 7 |
Arechavaleta | 2014 | Mexico | Ovary cancer | Latin | HB | 51 | 37 | 12 | 24 | 15 | 5 | 26 | 6 | 0.013 | PCR-RFLP | 49 (25–82) | 39 (13–77) | 7 |
Wieczorek | 2013 | Poland | Bladder cancer | Caucasian | HB | 241 | 199 | 44 | 125 | 72 | 38 | 101 | 60 | 0.697 | RT PCR | 66.3 ± 10.6 | 66.1 ± 10.4 | 8 |
Srivastava | 2013 | India | Bladder cancer | Asian | HB | 200 | 200 | 11 | 90 | 99 | 24 | 84 | 92 | 0.478 | PCR-based | 58.5 ± 12.4 | 56.8 ± 10.8 | 8 |
Kim | 2011 | Korea | Gastric cancer | Asian | HB | 148 | 315 | 14 | 67 | 67 | 38 | 127 | 150 | 0.172 | GoldenGate | mean 57.8 | mean 55.2 | 7 |
Debniak | 2011 | Poland | MM | Caucasian | PB | 296 | 290 | 58 | 152 | 86 | 43 | 134 | 113 | 0.750 | TaqMan | mean 56.0 | mean 55.0 | 8 |
Qiu | 2008 | China Mainland | HCa | Asian | HB | 417 | 480 | 81 | 196 | 140 | 80 | 216 | 184 | 0.223 | PCR-RFLP | NA | NA | 8 |
Lys460Thr | CC | CA | AA | CC | CA | AA | ||||||||||||
Tsai | 2018 | Taiwan | Bladder cancer | Asian | PB | 375 | 375 | 3 | 7 | 365 | 4 | 9 | 362 | < 0.001 | PCR-RFLP | mean 61.4 | mean 62.9 | 7 |
Hsiao | 2018 | Taiwan | Breast cancer | Asian | PB | 1232 | 1232 | 7 | 26 | 1199 | 8 | 23 | 1201 | < 0.001 | PCR | NA | NA | 7 |
Pei | 2017 | Taiwan | Leukemia | Asian | PB | 266 | 266 | 0 | 2 | 264 | 0 | 3 | 263 | 0.926 | PCR-RFLP | mean 7.0 | mean 8.3 | 7 |
Shen | 2017 | Taiwan | Lung cancer | Asian | PB | 358 | 715 | 0 | 3 | 355 | 0 | 4 | 711 | 0.940 | PCR-RFLP | mean 64.0 | mean 64.8 | 7 |
Hung | 2017 | Taiwan | Oral cancer | Asian | PB | 788 | 956 | 0 | 7 | 781 | 0 | 10 | 946 | 0.871 | PCR | mean 55.8 | mean 56.6 | 7 |
Lys87Glu | AA | AG | GG | AA | AG | GG | ||||||||||||
Nan | 2008 | USA | Skin Cancer | Caucasian | PB | 206 | 827 | 56 | 104 | 46 | 222 | 409 | 196 | 0.776 | TaqMan | mean 63.4 | mean 64.5 | 7 |
Kader | 2006 | USA | Invasive BCa | Caucasian | HB | 236 | 546 | 61 | 106 | 69 | 115 | 278 | 153 | 0.587 | RT PCR | 65 (21–88) | 64 (24–89) | 7 |
Kader | 2006 | USA | Superficial BCa | Caucasian | HB | 307 | 546 | 70 | 152 | 85 | 115 | 278 | 153 | 0.587 | RT PCR | 65 (21–88) | 64 (24–89) | 7 |